FDA wins major victory in campaign against stem cell clinics that marketing bogus and potentially hazardous products

One bioethical issue our Observatory is following is the proliferation of clinics offering stem cell treatments, many of which do not meet the necessary quality requirements. We published our first article on this problem in 2017 (see HERE and also North America’s two cell...